Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Roghayeh Mohammadzadeh, Saman Soleimanpour, Abbas Pishdadian & Hadi Farsiani. (2022) Designing and development of epitope-based vaccines against Helicobacter pylori. Critical Reviews in Microbiology 48:4, pages 489-512.
Read now
Read now
Henderson Zhu, Christine S. Rollier & Andrew J. Pollard. (2021) Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Review of Vaccines 20:12, pages 1515-1538.
Read now
Read now
Clara Carreras-Abad, Laxmee Ramkhelawon, Paul T Heath & Kirsty Le Doare. (2020) A Vaccine Against Group B Streptococcus: Recent Advances. Infection and Drug Resistance 13, pages 1263-1272.
Read now
Read now
Stefan Alexandru Artene, Cristian Tuţă, Alexandra Dragoi, Oana Alexandru, Purcaru Stefana Oana, Daniela Elise Tache, Maria Mihaela Dănciulescu, Mihai Virgil Boldeanu, Cristian Adrian Siloşi & Anica Dricu. (2018) Current and emerging EGFR therapies for glioblastoma. Journal of Immunoassay and Immunochemistry 39:1, pages 1-11.
Read now
Read now
Articles from other publishers (18)
Davide Oldrini, Roberta Di Benedetto, Martina Carducci, Daniele De Simone, Luisa Massai, Renzo Alfini, Barbara Galli, Brunella Brunelli, Amanda Przedpelski, Joseph T. Barbieri, Omar Rossi, Carlo Giannelli, Rino Rappuoli, Francesco Berti & Francesca Micoli. (2023) Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines. Vaccines 11:12, pages 1770.
Crossref
Crossref
Gayathri Sam, Shuxiong Chen, Karren Plain, Ian Marsh, Mark E. Westman, John Stenos, Stephen R. Graves & Bernd H. A. Rehm. (2023) Diphtheria Toxoid Particles as Q Fever Vaccine. Advanced Functional Materials.
Crossref
Crossref
Nisha Dhar, Ebrahim Mohamed, Frank Kirstein, Matthew Williams, Shantal Dorasamy, Petrus van Zyl, Madelyn Johnstone Robertson, Taigh Anderson, Lois M. Harden, Kimberly Jardine, Balaji Veeraraghavan, Seanette Wilson, Patrick Tippoo, Shabir A. Madhi & Gaurav Kwatra. (2023) Immune responses against group B Streptococcus monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice. iScience 26:8, pages 107380.
Crossref
Crossref
Yeong Ok Baik, Youngjin Lee, Chankyu Lee, Soo Kyung Kim, Jooyoung Park, Meixiang Sun, DaYe Jung, Jin Young Jang, Tae Jun Yong, Jeong Woo Park, Sungho Jeong, Suwon Lim, Seung Hyun Han & Seuk Keun Choi. (2023) A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants. Vaccine 41:10, pages 1753-1759.
Crossref
Crossref
Linda Del Bino, Kitt Emilie Østerlid, Dung-Yeh Wu, Francesca Nonne, Maria Rosaria Romano, Jeroen Codée & Roberto Adamo. (2022) Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Chemical Reviews 122:20, pages 15672-15716.
Crossref
Crossref
E.A. Khatuntseva & N.E. Nifantiev. (2022) Cross reacting material (CRM197) as a carrier protein for carbohydrate conjugate vaccines targeted at bacterial and fungal pathogens. International Journal of Biological Macromolecules 218, pages 775-798.
Crossref
Crossref
Arun B. Arunachalam, Stacey Vile & Angel Rosas. (2022) A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines. Frontiers in Immunology 13.
Crossref
Crossref
Chakkumkal Anish, Michel Beurret & Jan Poolman. (2021) Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. npj Vaccines 6:1.
Crossref
Crossref
Fernanda G. Rocha, Aym Berges, Angie Sedra, Shirin Ghods, Neeraj Kapoor, Lucy Pill, Mary Ellen Davey, Jeff Fairman & Frank C. GibsonIIIIII. (2021) A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss. Frontiers in Oral Health 2.
Crossref
Crossref
Seuk Keun Choi, Yeong Ok Baik, Chan Wha Kim, Soo Kyung Kim, Il Nam Oh, Hyeseon Yoon, Dajung Yu & Chankyu Lee. (2021) An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults. Vaccine 39:19, pages 2620-2627.
Crossref
Crossref
Jing Zhao, Gang Hu, Yi Huang, Yingchun Huang, Xin Wei & Jianyou Shi. (2021) Polysaccharide conjugate vaccine: A kind of vaccine with great development potential. Chinese Chemical Letters 32:4, pages 1331-1340.
Crossref
Crossref
Ariel M Slifka, Byung Park, Lina Gao & Mark K Slifka. (2021) Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules. Clinical Infectious Diseases 72:2, pages 285-292.
Crossref
Crossref
Anthony Almudevar, Ravinder Kaur & Michael Pichichero. (2019) Statistical projection of post-vaccination antibody kinetics between dosing schedules. Vaccine 37:32, pages 4561-4567.
Crossref
Crossref
Yao Lei, Furong Zhao, Junjun Shao, Yangfan Li, Shifang Li, Huiyun Chang & Yongguang Zhang. (2019) Application of built-in adjuvants for epitope-based vaccines. PeerJ 6, pages e6185.
Crossref
Crossref
Francesco Berti. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic
123
137
.
Michael Bröker, Francesco Berti, Joerg Schneider & Ivo Vojtek. (2017) Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations. Vaccine 35:25, pages 3286-3294.
Crossref
Crossref
Amanda Tivnan, Tatjana Heilinger, Ed C. Lavelle & Jochen H. M. Prehn. (2016) Advances in immunotherapy for the treatment of glioblastoma. Journal of Neuro-Oncology 131:1, pages 1-9.
Crossref
Crossref
Miwako Kobayashi, Johan Vekemans, Carol J. Baker, Adam J. Ratner, Kirsty Le Doare & Stephanie J. Schrag. (2016) Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Research 5, pages 2355.
Crossref
Crossref